| Financial Year |
March 31 2023 |
| Monetary Funds |
868,286,731.45 |
| Held-for-trading Financial Assets |
68,839,995.16 |
| Notes Receivable |
9,101,265.30 |
| Accounts Receivable |
870,907,920.10 |
| Advances to Suppliers |
41,649,482.24 |
| Other Receivables |
63,597,852.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,196,891,591.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,939,978.98 |
| Other Current Assets |
103,473,323.61 |
| Total Current Assets |
3,230,853,874.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,358,697.78 |
| Long-term Equity Investment |
79,017,999.22 |
| Investment Properties |
96,119.13 |
| Fixed Assetes |
1,318,595,526.70 |
| Under-construction Projects |
693,724,910.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
219,967,112.92 |
| R&D expenses |
101,802,992.17 |
| Goodwill |
2,323,927,623.14 |
| Long-Term Deferred and Prepaid Expenses |
36,536,291.37 |
| Deferred Income Tax Assets |
66,572,504.18 |
| Other Non-Current Assets |
77,114,913.65 |
| Sub-Total of Non-Current Assets |
5,033,731,369.34 |
| Total Assets |
8,264,585,243.94 |
| Short-Term Loans |
459,700,814.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,075,131,591.04 |
| Accounts Payable |
208,872,254.16 |
| Accounts Received In Advance |
27,786.99 |
| Employee Compensation Payable |
72,642,313.05 |
| Taxes Payable |
82,595,941.19 |
| Interest Payable |
5,144,795.73 |
| Dividend Payable |
73,142,193.39 |
| Other payables |
366,622,012.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
79,298,919.53 |
| Other Current Liabilities |
9,945,344.12 |
| Sub-Total of Current Liabilities |
2,447,540,231.01 |
| Long-term Loans |
203,546,665.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,219,888.25 |
| Deferred Income Tax Liabilities |
18,295,987.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
471,079,831.24 |
| Total Liabilities |
2,918,620,062.25 |
| Paid-In Capital(Or Share Stock) |
824,595,705.00 |
| Capital Surplus |
2,398,685,917.33 |
| Surplus Reserve |
217,225,236.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,350,080,617.81 |
| Minority Stockholder's Interest |
552,996,232.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,792,968,949.03 |
| Owner's Equity（Stockholder's Equity） |
5,345,965,181.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,264,585,243.94 |
